The global 3D cell culture market size was valued at USD 1.5 billion in 2020 and is projected to grow at a CAGR of 10% during the forecast period. Because 3D cultures can closely mimic the typical morphology and microarchitecture of organs, they are widely used in studies that require in vivo model systems to analyze the effects of foreign bodies on body tissues and organs. Moreover, the biomimetic tissue constructs used to generate 3D organotypic structures have prompted many research institutions to adopt 3D cell culture techniques.
A full report of 3D Cell Culture Market available at https://www.orionmarketreports.com/3d-cell-culture-market/11635/
Key players profiled in this report include 3D Biotek, LLC, Advanced Biomatrix, Inc., Avantor, Inc., Becton, Dickinson, and Company, Corning Incorporated, InSphero AG, Lonza Group Ltd., Merck & Co., Inc., Synthecon, Incorporated, and Thermo Fisher Scientific Inc.
3D Cell Culture Market: Segmentation
By Product
• Scaffold-Based Platforms
• Scaffold-Free Platforms
• Gels
• Bioreactors
• Microchips
• Services
By Application
• Cancer Research
• Stem Cell Research
• Drug Discovery
• Regenerative Medicine
By End User
• Biotechnology & Pharmaceutical Companies
• Contract Research Laboratories
• Academic Institutes
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)